ASX - By Stock
|
ADO |
Re:
Ann: Operational Update - Clean Energy Technology
|
|
Manu3019
|
181 |
54K |
28 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
181
|
54K
|
28
|
|
ASX - By Stock
|
ADO |
Re:
why ADO is a multi multi bagger
|
|
Manu3019
|
905 |
244K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
905
|
244K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Technical Milestone - Anode Performance Update
|
|
Manu3019
|
135 |
40K |
1 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
135
|
40K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech secures $1.4m Qld Grant Funding
|
|
Manu3019
|
244 |
77K |
5 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
244
|
77K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech secures $1.4m Qld Grant Funding
|
|
Manu3019
|
244 |
77K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
244
|
77K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Manu3019
|
9.2K |
2.8M |
19 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
9.2K
|
2.8M
|
19
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech $6.0m Capital Raising
|
|
Manu3019
|
74 |
27K |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
74
|
27K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Trading Halt
|
|
Manu3019
|
192 |
60K |
1 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
192
|
60K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Shooting the breeze on ADO
|
|
Manu3019
|
5.6K |
1.5M |
3 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
5.6K
|
1.5M
|
3
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Manu3019
|
9.2K |
2.8M |
0 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
9.2K
|
2.8M
|
0
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Manu3019
|
9.2K |
2.8M |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
9.2K
|
2.8M
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Manu3019
|
191 |
55K |
6 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
191
|
55K
|
6
|
|
ASX - By Stock
|
ADO |
Re:
Shooting the breeze on ADO
|
|
Manu3019
|
5.6K |
1.5M |
0 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
5.6K
|
1.5M
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Manu3019
|
216 |
61K |
2 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
216
|
61K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Manu3019
|
9.2K |
2.8M |
2 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
9.2K
|
2.8M
|
2
|
|
ASX - By Stock
|
ADO |
Re:
ADO Media Thread
|
|
Manu3019
|
1.4K |
451K |
7 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
1.4K
|
451K
|
7
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Manu3019
|
9.2K |
2.8M |
3 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
9.2K
|
2.8M
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Therapeutic Goods Administration Registration Submitted
|
|
Manu3019
|
649 |
201K |
2 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
649
|
201K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Webinar
|
|
Manu3019
|
178 |
56K |
5 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
178
|
56K
|
5
|
|
ASX - By Stock
|
ADO |
Re:
Qld COVID-19 testing kits await local use
|
|
Manu3019
|
161 |
50K |
2 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
161
|
50K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Signs UK Distribution Agreement for EuGeni
|
|
Manu3019
|
204 |
71K |
9 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
204
|
71K
|
9
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
3 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Pre AGM Share price prediction. EOD Friday 5th Nov 2021
|
|
Manu3019
|
136 |
52K |
3 |
11/07/21 |
11/07/21 |
ASX - By Stock
|
136
|
52K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
2 new employees
|
|
Manu3019
|
193 |
90K |
23 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
193
|
90K
|
23
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
3 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
3
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
4 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
4
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
2 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
2
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
1 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
1
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
0 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Updated Company Presentation
|
|
Manu3019
|
65 |
26K |
2 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
65
|
26K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
ADO Price Prediction
|
|
Manu3019
|
453 |
150K |
0 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
453
|
150K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
ADO Price Prediction
|
|
Manu3019
|
453 |
150K |
0 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
453
|
150K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
2 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
2
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Manu3019
|
9.2K |
2.8M |
1 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
9.2K
|
2.8M
|
1
|
|
ASX - By Stock
|
ADO |
Re:
ADO Charting and Technical Analysis
|
|
Manu3019
|
9.2K |
2.8M |
1 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
9.2K
|
2.8M
|
1
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
Manu3019
|
3.3K |
1.1M |
2 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Rapid Testing Competition
|
|
Manu3019
|
12 |
3.6K |
0 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
12
|
3.6K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Chart of the day
|
|
Manu3019
|
7 |
2.4K |
0 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
7
|
2.4K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
ELLUME news
|
|
Manu3019
|
130 |
43K |
12 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
130
|
43K
|
12
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Activities Report
|
|
Manu3019
|
142 |
40K |
3 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
142
|
40K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Appendix 4C - quarterly
|
|
Manu3019
|
29 |
8.3K |
7 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
29
|
8.3K
|
7
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Up to $1.4m in Qld Grant for COVID-19 test development
|
|
Manu3019
|
142 |
43K |
2 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
142
|
43K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Progresses COVID-19 Test Toward Market Launch
|
|
Manu3019
|
960 |
278K |
0 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
960
|
278K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Progresses COVID-19 Test Toward Market Launch
|
|
Manu3019
|
960 |
278K |
1 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
960
|
278K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Corona virus Antibody tests
|
|
Manu3019
|
74 |
23K |
1 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
74
|
23K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Corona virus Antibody tests
|
|
Manu3019
|
74 |
23K |
2 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
74
|
23K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
2021 - The year for ADO
|
|
Manu3019
|
10 |
3.7K |
1 |
31/12/20 |
31/12/20 |
ASX - By Stock
|
10
|
3.7K
|
1
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Progresses COVID-19 Test Toward Market Launch
|
|
Manu3019
|
960 |
278K |
0 |
24/12/20 |
24/12/20 |
ASX - By Stock
|
960
|
278K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ellume 250,000 test per day by Mar 2021
|
|
Manu3019
|
156 |
50K |
3 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
156
|
50K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
ADO Analysis
|
|
Manu3019
|
4.3K |
2.5M |
2 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
4.3K
|
2.5M
|
2
|
|